Calcitonin secretion and bone disease severity in hypercalcaemic hyperparathyroidism

Area of Science:

• Endocrinology
• Bone Metabolism
• Calcium Homeostasis

Background:

• Primary hyperparathyroidism is characterized by elevated parathyroid hormone and often hypercalcemia.
• Calcitonin (CT) plays a role in calcium regulation and bone metabolism.
• The impact of CT secretion on bone disease severity in primary hyperparathyroidism requires further elucidation.

Purpose of the Study:

• To investigate the relationship between plasma calcitonin (CT) levels and urinary hydroxyproline (OHPr) excretion in patients with primary hyperparathyroidism.
• To determine the effect of CT secretion on the severity of bone disease in this patient cohort.
• To explore potential sex-based differences in CT secretion and bone involvement.

Main Methods:

• Plasma CT levels and urinary hydroxyproline (OHPr) excretion were measured in 28 patients (11 males, 17 females) with primary hyperparathyroidism.
• Correlation analysis was performed between CT levels, serum calcium, and OHPr excretion.
• Sex-specific differences in CT levels and their association with bone disease markers were assessed.

Main Results:

• Approximately 50% of patients with primary hyperparathyroidism exhibited increased plasma CT levels, irrespective of sex.
• Plasma CT levels correlated with serum calcium in males but not in females.
• Higher urinary OHPr excretion was observed in patients with lower plasma CT levels, particularly in females who also showed a higher incidence of undetectable CT levels.

Conclusions:

• Chronic hypercalcemia in primary hyperparathyroidism may lead to a diminished functional reserve of CT-secreting parafollicular cells.
• Females may be at higher risk for more severe bone disease due to a potentially lower intrinsic CT secretory reserve compared to males.
• These findings suggest a sex-specific role for calcitonin in modulating bone involvement in primary hyperparathyroidism.